Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Inhibition of cyclin-dependent kinases - a review of the recent patent literature.

Inhibition of cyclin-dependent kinases - a review of the recent patent literature. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Inhibition of cyclin-dependent kinases - a review of the recent patent literature. Abstract Text:

    andrea d bassoAndrea D Basso,ronald j dollRonald J Doll,andrea d bassoAndrea D Basso,ronald j dollRonald J Doll,andrea d bassoAndrea D Basso,ronald j dollRonald J Doll,

    The cyclin dependent kinases, Cdks, are potential targets for new anticancer therapy. Dysregulation of the cell cycle is common during tumorigenesis, and inhibition of certain Cdks has been shown to inhibit tumor cell growth, induce apoptosis and cause tumor regressions in animal models. This review discusses the rationale for inhibiting Cdks as an approach to cancer therapy and the status of Cdk inhibitors in clinical trials. Compounds resulting from a patent literature search from 2003 to July, 2005 are discussed.

    Inhibition of cyclin-dependent kinases - a review of the recent patent literature. Publishing Authors By Initials

    ad bassoAD Basso,rj dollRJ Doll,ad bassoAD Basso,rj dollRJ Doll,ad bassoAD Basso,rj dollRJ Doll,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Inhibition of cyclin-dependent kinases - a review of the recent patent literature. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Recent patents on anti-cancer drug discovery

    VOLUME: 1

    Page Numbers: 357-67

    Journal Abbreviation:

    ISSN: 1574-8928

    DAY: 28

    MONTH: Nov

    YEAR: 2006

    Inhibition of cyclin-dependent kinases - a review of the recent patent literature. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101266081

    Inhibition of cyclin-dependent kinases - a review of the recent patent literature. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Inhibition of cyclin-dependent kinases - a review of the recent patent literature. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Inhibition of cyclin-dependent kinases - a review of the recent patent literature.

    AFFILIATION: Schering-Plough Research Institute, Department of Tumor Biology, Departmant of Chemical Research, 2015 Galloping Hill Road, Kenilworth, NJ 07033-1300, USA. ronald.doll@spcorp.com.

    Country: United Arab Emirates

    United Arab Emirates Research PublicationUnited Arab Emirates Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Recent Patents Anticancer Drug

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Inhibition of cyclin-dependent kinases - a review of the recent patent literature Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News